蘭尼單抗（Lucentis?）（人類）ELISA試劑盒-Ranibizumad (Lucentis代理/參數/廠家-細胞分析試劑盒-艾美捷科技有限公司

PRODUCT CENTER

細胞分析試劑盒

產品中心

當前位置：首頁 > 產品中心 > 細胞生物學產品 > 細胞分析試劑盒

產品描述: Ranibizumab (Lucentis?) is a recombinant human IgG1 monoclonal antibody fragment (Fab) that blocks angiogenesis by inhibiting vascular endothelial growth factor-A (VEGF-A) isoforms. The humanized anti-VEGF monoclonal antibody, Ranibizumab, has been approved by the FDA for treatment of patients with wet age-related macular degeneration. Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in people over the age of 50 in the developed world. Although an estimated 80% of patients with AMD have the non-neo vascular form, the neo vascular (wet or exudative) form is responsible for almost 90% of severe visual loss resulting from AMD. Currently, the most commonly used VEGF antagonists are ranibizumab (Lucentis, Genentech, Inc.) and Ranibizumab (Avastin; Genentech, Inc.). Ranibizumab, which is an antibody fragment form the Ranibizumab molecule with an increased binding affinity for all forms of VEGF, has been approved for the treatment of patients with neo-vascular AMD by the Food and Drug Administration and by the European Medicines Agency. BioVision’s Ranibizumab ELISA kit is developed for the quantification of Ranibizumab concentration in human serum or plasma with high sensitivity and reproducibility.

產品特點: Easy, convenient, sensitive and time-saving method to measure the level of Ranibizumad in human serum and plasma. Detection Range: 1.22 – 625 ng/ml

其他: BioVision的公司總部在美麗的舊金山灣地區，它是全球生命科學公司的領導者.BioVision在開發和研究細胞凋亡檢測分析、代謝檢測方面具有卓越的影響力.包括檢測各種檢測分析試劑盒、相關特色抗體、重組蛋白及細胞因子和酶等多種產品，以及其他創新的研究工具.其產品覆蓋細胞凋亡研究、能量代謝、細胞/組織蛋白提取、氧化應激與損傷、代謝與肥胖癥、細胞增殖與毒性、信號轉導、干細胞研究等領域.作為多家知名品牌的中國總代理以及中國區域代理，艾美捷與BioVision一起為研究者們提供最好、最新的細胞生物學研究工具而不斷擴大產品及服務質量.